John Minni, DO
Dermatology · Stuart, FLNPI 1144303009
Payments from drug & device makers
Across 2,023 payments — averaging $684.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$227K
- AbbVie$199K
- Janssen Scientific Affairs, LLC$162K
- Regeneron Healthcare Solutions, Inc.$147K
- UCB, Inc.$144K
- Sanofi$96K
- plus $410K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 287 | $226,800 |
| AbbVie | 291 | $198,722 |
| Janssen Scientific Affairs, LLC | 125 | $162,202 |
| Regeneron Healthcare Solutions, Inc. | 223 | $147,228 |
| UCB, Inc. | 166 | $143,846 |
| Sanofi | 98 | $96,012 |
| Amgen(2 entities) | 115 | $77,139 |
| Galderma Laboratories, L.p. | 99 | $67,061 |
| Novartis | 82 | $59,495 |
| Incyte Corporation | 94 | $51,476 |
| E.r. Squibb & Sons, L.L.C. | 93 | $51,434 |
| LEO Pharma Inc. | 73 | $36,576 |
| Organon | 38 | $27,204 |
| Bristol Myers Squibb | 25 | $19,994 |
| Lilly USA, LLC | 23 | $10,484 |
| Pfizer | 26 | $5,214 |
| Dermavant Sciences, Inc. | 71 | $2,961 |
| Arcutis Biotherapeutics, Inc. | 61 | $504 |
| Sun Pharmaceutical Industries Inc. | 11 | $222 |
| Sanofi-aventis U.S. LLC | 2 | $119 |
| Almirall LLC | 5 | $94 |
| Dermira, Inc. | 3 | $66 |
| Genentech USA, Inc. | 3 | $65 |
| Mayne Pharma Commercial LLC | 2 | $53 |
| Boehringer Ingelheim | 2 | $44 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Smith+Nephew | 1 | $24 |
| Mylan Institutional Inc. | 1 | $22 |
| Biofrontera Inc. | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $17 |
How this compares
$1,385,124 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Stuart
- Michael SherlingLake Worth$78.9M
- Seth FormanTampa$28.2M
- Thomas TaylorTampa$13.6M
- Frank DonHallandale Beach$7.5M
- Francisco FloresMiramar$6.7M
- Hector Wiltz JrMiami$6.4M
- Javier Alonso-LlamazaresCoral Gables$5.6M
- Eduardo WeissHollywood$5.5M
- Francisco KerdelMiami$5.1M
- Jason SluzevichJacksonville$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.